These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20025469)

  • 1. Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy.
    Lin MM; Kim HH; Kim H; Dobson J; Kim DK
    Nanomedicine (Lond); 2010 Jan; 5(1):109-33. PubMed ID: 20025469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.
    Kievit FM; Zhang M
    Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
    Rosen JE; Chan L; Shieh DB; Gu FX
    Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
    Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
    Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
    Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
    J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
    Santhosh PB; Ulrih NP
    Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
    Schleich N; Po C; Jacobs D; Ucakar B; Gallez B; Danhier F; Préat V
    J Control Release; 2014 Nov; 194():82-91. PubMed ID: 25178270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging.
    Das M; Mishra D; Dhak P; Gupta S; Maiti TK; Basak A; Pramanik P
    Small; 2009 Dec; 5(24):2883-93. PubMed ID: 19856326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
    Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
    Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting nanoparticles to cancer.
    Wang M; Thanou M
    Pharmacol Res; 2010 Aug; 62(2):90-9. PubMed ID: 20380880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of magnetic nanoparticles in biomedical applications.
    Naqvi S; Samim M; Dinda AK; Iqbal Z; Telagoanker S; Ahmed FJ; Maitra A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):153-61. PubMed ID: 19519575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
    Yhee JY; Lee S; Kim K
    Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy.
    Liang S; Wang Y; Yu J; Zhang C; Xia J; Yin D
    J Mater Sci Mater Med; 2007 Dec; 18(12):2297-302. PubMed ID: 17562137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies.
    Zhang C; Yan Y; Zou Q; Chen J; Li C
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):13-21. PubMed ID: 26663873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
    Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
    J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
    Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
    Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
    Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
    ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising iron oxide-based magnetic nanoparticles in biomedical engineering.
    Tran PH; Tran TT; Vo TV; Lee BJ
    Arch Pharm Res; 2012 Dec; 35(12):2045-61. PubMed ID: 23263800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.